BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-12.68%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.45B
AUM Growth
+$2.45B
(-17%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
4.62%
Top 10 Holdings %
Top 10 Hldgs %
73.47%
Holding
55
New
2
Increased
12
Reduced
5
Closed
4
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$57.7M |
| 2 |
Axsome Therapeutics
AXSM
|
$35.2M |
| 3 |
Kura Oncology
KURA
|
$34.2M |
| 4 |
Protagonist Therapeutics
PTGX
|
$32.6M |
| 5 |
Revolution Medicines
RVMD
|
$28.3M |
Top Sells
| 1 |
Agios Pharmaceuticals
AGIO
|
$35.3M |
| 2 |
89bio
ETNB
|
$33.9M |
| 3 |
GH Research
GHRS
|
$17.3M |
| 4 |
enGene Holdings
ENGN
|
$14M |
| 5 |
Xoma
XOMA
|
$13M |
Sector Composition
| 1 | Healthcare | 99.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Foghorn Therapeutics
FHTX
$298M
| $19.4M | 0.79% |
5,302,000
| – | – |
|
|
ITOS
27
DELISTED
iTeos Therapeutics
ITOS
| $18.4M | 0.75% |
3,075,000
+750,000
| +32% | +$4.48M |
|
28
4D Molecular Therapeutics
FDMT
$302M
| $14.7M | 0.6% |
4,561,289
+1,890,647
| +71% | +$6.11M |
|
29
ESSA Pharma
EPIX
$11.2M
| $13.8M | 0.56% |
8,748,629
| – | – |
|
30
Annexon
ANNX
$225M
| $13.5M | 0.55% |
7,000,000
| – | – |
|
31
Verastem
VSTM
$585M
| $12.7M | 0.52% |
2,100,468
| – | – |
|
32
RAPT Therapeutics
RAPT
$187M
| $11.3M | 0.46% |
9,237,556
| – | – |
|
33
Repare Therapeutics
RPTX
$73.9M
| $10.2M | 0.42% |
10,333,600
| – | – |
|
34
Immunic
IMUX
$79.4M
| $9.7M | 0.4% |
8,902,972
| – | – |
|
35
Avalo Therapeutics
AVTX
$139M
| $8.3M | 0.34% |
1,036,679
| – | – |
|
|
THRD
36
DELISTED
Third Harmonic Bio
THRD
| $8.23M | 0.34% |
2,372,933
| – | – |
|
|
VIGL
37
DELISTED
Vigil Neuroscience
VIGL
| $7.14M | 0.29% |
4,013,633
+2,200,000
| +121% | +$3.92M |
|
38
TScan Therapeutics
TCRX
$106M
| $6.75M | 0.28% |
4,889,474
+1,900,000
| +64% | +$2.62M |
|
|
MOLN
39
Molecular Partners
MOLN
$139M
| $5.51M | 0.22% |
1,353,968
| – | – |
|
|
IMA
40
ImageneBio, Inc. Common Stock
IMA
$153M
| $5.13M | 0.21% |
4,006,564
| – | – |
|
41
Forte Biosciences
FBRX
$138M
| $4.61M | 0.19% |
594,282
| – | – |
|
|
ALLK
42
DELISTED
Allakos
ALLK
| $3.77M | 0.15% |
16,552,417
| – | – |
|
43
CytomX Therapeutics
CTMX
$350M
| $3.32M | 0.14% |
5,228,461
| – | – |
|
44
Tenax Therapeutics
TENX
$27.5M
| $2.22M | 0.09% |
339,549
| – | – |
|
|
IVA
45
Inventiva
IVA
$802M
| $2.06M | 0.08% |
686,040
| – | – |
|
|
CBIO
46
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $2M | 0.08% |
9,544,262
| – | – |
|
47
SAB Biotherapeutics
SABS
$21.6M
| $1.24M | 0.05% |
917,826
| – | – |
|
48
NewAmsterdam Pharma
NAMS
$2.8B
| $1.21M | 0.05% |
+59,065
| New | +$1.21M |
|
49
Ovid Therapeutics
OVID
$94.6M
| $1.2M | 0.05% |
3,853,818
| – | – |
|
|
50
enGene Holdings Inc. Warrants
ENGNW
$7.29M
| $605K | 0.02% |
945,402
| – | – |
|